Literature DB >> 12887398

Exclusion of candidate genes in two families with autosomal dominant hypocalcified amelogenesis imperfecta.

P Suzanne Hart1, J Timothy Wright, Mathew Savage, George Kang, Jeannette T Bensen, Michael C Gorry, Thomas C Hart.   

Abstract

The amelogenesis imperfectas (AI) are a group of hereditary enamel defects characterized by clinical and genetic diversity. The most common AI types are inherited as autosomal traits. Three mutations of the enamelin (ENAM) gene have been found in cases of autosomal dominant hypoplastic AI. The gene(s) responsible for hypocalcified forms of AI have not been identified, although a number of autosomal genes have been proposed as candidates for AI based on their expression by ameloblasts, including ameloblastin and enamelin (chromosome 4q13.3), tuftelin (chromosome 1q21), enamelysin (chromosome 11q22.3-q23) and kallikrein 4 (chromosome 19q13.3-q13.4). To localize the gene(s) responsible for autosomal dominant hypocalcified AI, we evaluated support for/against linkage of AI to genetic markers spanning five AI candidate genes in two extended families. Our data excluded all proposed candidate gene regions as causal for autosomal dominant hypocalcified AI in these families. These linkage findings provide further evidence for genetic heterogeneity among families with autosomal dominant AI and indicate that, at least, some forms of autosomal dominant hypocalcified AI are not caused by a gene in the five most commonly reported AI candidate genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887398     DOI: 10.1034/j.1600-0722.2003.00046.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  11 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

Review 2.  The molecular etiologies and associated phenotypes of amelogenesis imperfecta.

Authors:  J Timothy Wright
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

3.  A comprehensive analysis of normal variation and disease-causing mutations in the human DSPP gene.

Authors:  Dianalee A McKnight; P Suzanne Hart; Thomas C Hart; James K Hartsfield; Anne Wilson; J Timothy Wright; Larry W Fisher
Journal:  Hum Mutat       Date:  2008-12       Impact factor: 4.878

4.  FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta.

Authors:  Jung-Wook Kim; Sook-Kyung Lee; Zang Hee Lee; Joo-Cheol Park; Kyung-Eun Lee; Myoung-Hwa Lee; Jong-Tae Park; Byoung-Moo Seo; Jan C-C Hu; James P Simmer
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

Review 5.  Interventions for the restorative care of amelogenesis imperfecta in children and adolescents.

Authors:  Mayssoon Dashash; C Albert Yeung; Issam Jamous; Anthony Blinkhorn
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

Review 6.  Protein-mediated enamel mineralization.

Authors:  Janet Moradian-Oldak
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

7.  Amelogenesis imperfecta: Report of a case and review of literature.

Authors:  Mayur Chaudhary; Shweta Dixit; Asha Singh; Sanket Kunte
Journal:  J Oral Maxillofac Pathol       Date:  2009-07

8.  Exclusion of known gene for enamel development in two Brazilian families with amelogenesis imperfecta.

Authors:  Maria C L G Santos; P Suzanne Hart; Mukundhan Ramaswami; Cláudia M Kanno; Thomas C Hart; Sergio R P Line
Journal:  Head Face Med       Date:  2007-01-31       Impact factor: 2.151

9.  Missense Mutation in Fam83H Gene in Iranian Patients with Amelogenesis Imperfecta.

Authors:  S Jalal Pourhashemi; Mehdi Ghandehari Motlagh; Ghasem Meighani; Azadeh Ebrahimi Takaloo; Mahsa Mansouri; Fatemeh Mohandes; Maryam Mirzaii; Ahad Khoshzaban; Faranak Moshtaghi; Hoda Abedkhojasteh; Mansour Heidari
Journal:  Iran J Public Health       Date:  2014-12       Impact factor: 1.429

10.  Evolutionary analysis of selective constraints identifies ameloblastin (AMBN) as a potential candidate for amelogenesis imperfecta.

Authors:  Frédéric Delsuc; Barbara Gasse; Jean-Yves Sire
Journal:  BMC Evol Biol       Date:  2015-07-30       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.